Featured Product
This Week in Quality Digest Live
FDA Compliance Features
Jill Roberts
Another way to know what’s too old to eat
Patricia Santos-Serrao
Four pharma quality trends
Del Williams
Preventing damage caused by large, suspended particles
Kari Miller
An effective strategy requires recruiting qualified personnel familiar with the process and technology

More Features

FDA Compliance News
Now is not the time to skip critical factory audits and supply chain assessments
Google Docs collaboration, more efficient management of quality deviations
Delivers time, cost, and efficiency savings while streamlining compliance activity
First trial module of learning tool focuses on ISO 9001 and is available now
Free education source for global medical device community
Good quality is adding an average of 11 percent to organizations’ revenue growth
Further enhances change management capabilities
Creates adaptive system for managing product development and post-market quality for devices with software elements
VQIP allows for expedited review and importation for approved applicants that demonstrate safe supply chains

More News

FDAnews

FDA Compliance

Third Annual Supplier Quality Management Congress

Aug. 9–11, 2011, in Bethesda, MD

Published: Tuesday, June 28, 2011 - 18:29

(FDAnews: Falls Church, VA) -- Despite the FDAs ongoing work with international regulators to improve supplier quality issues, a top FDA official has stated that another public health crisis like Heparin, which occurred in 2010 when Baxter Healthcare distributed misbranded and contaminated doses of the drug, “seems inevitable.”

All together, the number of offshore suppliers has nearly tripled in recent years. China alone has nearly 1,000 makers of drug substances and only a small percentage of inspections.

Whether you make drugs or devices, biologics, or third-party goods, when your suppliers slip up, it’s you the FDA comes after. Ideally, regulators should be covering your back with tough inspections of offshore suppliers, but realistically, the agency simply is spread too thin to do the job.

Learn how to ensure the integrity and quality of your supply chain. Put yourself at the head of the class and avoid 483s (FDA warning letters) and lawsuits by taking the lead. You can take charge of your supply chain by joining the top speakers in Washington in August to learn about the tools you need. Mark your calendar for the Third Annual Supplier Quality Management Congress, scheduled for Aug. 9–11, 2011, in Bethesda, Maryland.

The congress consists of a day and a half of intensive learning, a crash course in supply-chain management and monitoring. Here’s just a sample of what you’ll discover:
• The FDA outlook on supplier quality and compliance
• How to create comprehensive supplier quality agreements
• An assessment tool for choosing the right supplier
• How to conduct on-site supplier audits and apply best-practice risk management techniques
• Supplier metrics and their role in the quality management system (QMS) management review
• Can’t-miss audit plans and supplier quality-auditor training programs
• Special for device makers: Updates on the Global Harmonization Task Force (GHTF) and device outsourcing trends
• Special for drug and biologics manufacturers: Creating qualification management systems

Presenters include an all-star cast of industry stars, members of the bar, consultants, and invited FDA officials, including:
• Kimberly Trautman, medical device quality systems/GMP expert, Office of Compliance, CDRH, FDA
• Jan Welch, consumer safety officer, Office of Compliance, CDRH, FDA
• David Jaworski, consumer safety officer, Division of Manufacturing and Product Quality, CDER, FDA
• Larry Spears, deputy director for regulatory affairs, CDRH, FDA
• Steven Wolfgang, consumer safety officer, Division of Manufacturing and Product Quality, CDER, FDA

Conference co-chairs John Avellanet of Cerulean Associates LLC and Steven Sharf of GMP Concepts will be on hand to keep matters on track and moving forward.

Workshop A—Medical Device Supplier Qualification and Management: Practical Approaches to Cost-Effective Implementation

Regulators worldwide are looking more closely at supplier-management issues as device manufacturers extend their processes down the supply chain and acquire components across national boundaries.

Are you ready for the increased scrutiny from FDA investigators and Notified Bodies?

Workshop B—The Pre-audit Supplier Questionnaire: How to Make It Relevant and Useful

At one time or another, we have all either sent out a pre-audit questionnaire or have been on the receiving end of one with a due date of about two weeks. That’s two weeks to complete a document of more than 20 pages.

Pre-audit questionnaires should be treated like audit reports and put together with the same kind of thought and care that we complete our reports. Suppliers see 50 of these a year, and each time they think to themselves, “Another questionnaire that no one will look at.” Let's change that and make it a value-added document.

Click here to see the full conference brochure and register.

Discuss

About The Author

FDAnews’s picture

FDAnews

FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the U.S. Food and Drug Administration (FDA). Pharmaceutical and medical device professionals rely on FDAnews’ print and electronic newsletters, books, special reports, and conferences to stay in compliance with international standards and FDA’s complex and ever-changing regulations to get their products to market faster and boost profits.